Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells

Overview of attention for article published in Frontiers in Physiology, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 100 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

ANTI-FLT-1 ANTIBODIES FOR TREATING DUCHENNE MUSCULAR DYSTROPHY

Application EP-4056593-A1

European Patent Office

METHOD OF TREATING DUCHENNE MUSCULAR DYSTROPHY BY ADMINISTERING AN ANTI-Flt-1 ANTIBODY

Application EA-037501-B1

Eurasian Patent Organisation

ANTI-FLT-1 ANTIBODIES FOR TREATING DUCHENNE MUSCULAR DYSTROPHY

Application WO-2016164528-A1

World Intellectual Property Organisation (WIPO)

ANTI-FLT-1 ANTIBODIES IN TREATING DUCHENNE MUSCULAR DYSTROPHY

Application WO-2014117160-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.